518 related articles for article (PubMed ID: 36974770)
1. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF.
Farmakis D; Tromp J; Marinaki S; Ouwerkerk W; Angermann CE; Bistola V; Dahlstrom U; Dickstein K; Ertl G; Ghadanfar M; Hassanein M; Obergfell A; Perrone SV; Polyzogopoulou E; Schweizer A; Boletis I; Cleland JGF; Collins SP; Lam CSP; Filippatos G
Eur J Heart Fail; 2023 Jun; 25(6):818-828. PubMed ID: 36974770
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
[TBL] [Abstract][Full Text] [Related]
3. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
[TBL] [Abstract][Full Text] [Related]
4. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
[TBL] [Abstract][Full Text] [Related]
5. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
6. Recurrent hospitalizations are associated with increased mortality across the ejection fraction range in heart failure.
Huusko J; Tuominen S; Studer R; Corda S; Proudfoot C; Lassenius M; Ukkonen H
ESC Heart Fail; 2020 Oct; 7(5):2406-2417. PubMed ID: 32667143
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction - insights from the ESC-HFA EORP Heart Failure Long-Term Registry.
Kapłon-Cieślicka A; Benson L; Chioncel O; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Ruschitzka F; Hage C; Drożdż J; Seferovic P; Rosano GMC; Piepoli M; Mebazaa A; McDonagh T; Lainscak M; Savarese G; Ferrari R; Maggioni AP; Lund LH;
Eur J Heart Fail; 2022 Feb; 24(2):335-350. PubMed ID: 34962044
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
Chen X; Savarese G; Dahlström U; Lund LH; Fu M
Clin Res Cardiol; 2019 Dec; 108(12):1394-1405. PubMed ID: 30980205
[TBL] [Abstract][Full Text] [Related]
9. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
[TBL] [Abstract][Full Text] [Related]
10. Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction.
López-Azor JC; Delgado JF; Vélez J; Rodríguez R; Solís J; Del Oro M; Ortega C; Salguero-Bodes R; Palacios B; Vicent L; Moreno G; Rosillo N; Varela L; Capel M; Arribas F; Bernal JL; Bueno H
Rev Esp Cardiol (Engl Ed); 2023 Nov; 76(11):862-871. PubMed ID: 37331588
[TBL] [Abstract][Full Text] [Related]
11. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
[TBL] [Abstract][Full Text] [Related]
12. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
Si J; Ding Z; Hu Y; Zhang X; Zhang Y; Cao H; Liu Y
J Cardiol; 2024 Apr; 83(4):250-257. PubMed ID: 37802201
[TBL] [Abstract][Full Text] [Related]
13. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
Vaduganathan M; Piccini JP; Camm AJ; Crijns HJGM; Anker SD; Butler J; Stewart J; Braceras R; Albuquerque APA; Wieloch M; Hohnloser SH
Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
[TBL] [Abstract][Full Text] [Related]
14. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
[TBL] [Abstract][Full Text] [Related]
15. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
[TBL] [Abstract][Full Text] [Related]
16. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
Sartipy U; Dahlström U; Fu M; Lund LH
JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
Kroshian G; Joseph J; Kinlay S; Peralta AO; Hoffmeister PS; Singh JP; Yuyun MF
J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and prognosis of patients with different types of heart failure in relation to coronary artery disease].
Zhou Y; Mo T; Bao YP; Wang L; Zhong RR; Tian JL
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(15):1142-1147. PubMed ID: 32311877
[No Abstract] [Full Text] [Related]
19. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
